SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001279569-12-001174
Filing Date
2012-09-27
Accepted
2012-09-27 15:18:55
Documents
11
Period of Report
2012-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A lorus6k.htm 6-K/A 23232
2 ANIMAL RIGHTS LICENCE AGREEMENT DATED JUNE 19, 2009 ex991.htm EX-99.1 129498
3 ASSET PURCHASE AGREEMENT DATED JUNE 19, 2009 ex992.htm EX-99.2 214544
4 AMENDMENT, ASSIGNMENT, ASSUMPTION NOVATION AND CONSENT AGREEMENT DATED JUNE 19, ex993.htm EX-99.3 59985
5 SETTLEMENT AGREEMENT DATED JUNE 19, 2009 ex994.htm EX-99.4 75455
6 SHARE PURCHASE AGREEMENT DATED JUNE 19, 2009 ex995.htm EX-99.5 186854
7 SUPPLY AND SERVICES AGREEMENT DATED JUNE 19, 2009 ex996.htm EX-99.6 145826
8 LICENCE AGREEMENT DATED APRIL 8, 2008 ex997.htm EX-99.7 678223
9 ZOR PHARMACEUTICALS, LLC LIMITED LIABILITY COMPANY AGREEMENT ex998.htm EX-99.8 393342
10 INDEPENDENT CONTRATOR SERVICES AGREEMENT ex999.htm EX-99.9 45025
11 GRAPHIC graphic1.jpg GRAPHIC 402046
  Complete submission text file 0001279569-12-001174.txt   2507283
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K/A | Act: 34 | File No.: 001-32001 | Film No.: 121113045
SIC: 2836 Biological Products, (No Diagnostic Substances)